Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation
Status:
Completed
Trial end date:
2020-01-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of Pulmonary Vein Isolation (PVI)
performed with the Arctic Front™ Advance Cardiac CryoAblation Catheter System as first-line
therapy in comparison with antiarrhythmic drugs (AAD) in patients with paroxysmal atrial
fibrillation (AF).
Phase:
Phase 4
Details
Lead Sponsor:
Medtronic Atrial Fibrillation Solutions Medtronic Cardiac Rhythm and Heart Failure